Titre : Surdité mixte de transmission et neurosensorielle

Surdité mixte de transmission et neurosensorielle : Questions médicales fréquentes

Termes MeSH sélectionnés :

Early Detection of Cancer
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Surdité mixte de transmission et neurosensorielle : Questions médicales les plus fréquentes", "headline": "Surdité mixte de transmission et neurosensorielle : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Surdité mixte de transmission et neurosensorielle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-23", "dateModified": "2025-04-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Surdité mixte de transmission et neurosensorielle" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Perte d'audition", "url": "https://questionsmedicales.fr/mesh/D034381", "about": { "@type": "MedicalCondition", "name": "Perte d'audition", "code": { "@type": "MedicalCode", "code": "D034381", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.763.393.341" } } }, "about": { "@type": "MedicalCondition", "name": "Surdité mixte de transmission et neurosensorielle", "alternateName": "Hearing Loss, Mixed Conductive-Sensorineural", "code": { "@type": "MedicalCode", "code": "D046089", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Andrea Canale", "url": "https://questionsmedicales.fr/author/Andrea%20Canale", "affiliation": { "@type": "Organization", "name": "ENT Unit, Department of Surgical Sciences, University of Turin, Turin, Italy." } }, { "@type": "Person", "name": "Valerio Bordino", "url": "https://questionsmedicales.fr/author/Valerio%20Bordino", "affiliation": { "@type": "Organization", "name": "ENT Unit, Department of Surgical Sciences, University of Turin, Turin, Italy." } }, { "@type": "Person", "name": "Andrea Albera", "url": "https://questionsmedicales.fr/author/Andrea%20Albera", "affiliation": { "@type": "Organization", "name": "ENT Unit, Department of Surgical Sciences, University of Turin, Turin, Italy." } }, { "@type": "Person", "name": "Anastasia Urbanelli", "url": "https://questionsmedicales.fr/author/Anastasia%20Urbanelli", "affiliation": { "@type": "Organization", "name": "ENT Unit, Department of Surgical Sciences, University of Turin, Turin, Italy." } }, { "@type": "Person", "name": "Maria Gragnano", "url": "https://questionsmedicales.fr/author/Maria%20Gragnano", "affiliation": { "@type": "Organization", "name": "Department of Public Health Sciences and Paediatrics, University of Turin, Turin, Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Erratum: Non-cardia early gastric cancer in Central Vietnam: noticeable uncommon background mucosa and results of endoscopic submucosal dissection.", "datePublished": "2022-08-22", "url": "https://questionsmedicales.fr/article/36003304", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/a-1925-4922" } }, { "@type": "ScholarlyArticle", "name": "Imaging-Based Deep Graph Neural Networks for Survival Analysis in Early Stage Lung Cancer Using CT: A Multicenter Study.", "datePublished": "2022-07-13", "url": "https://questionsmedicales.fr/article/35936706", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fonc.2022.868186" } }, { "@type": "ScholarlyArticle", "name": "Toxicity and outcomes after external beam irradiation for prostate cancer in patients with prior holmium laser enucleation of the prostate: Early experience.", "datePublished": "2022-07-05", "url": "https://questionsmedicales.fr/article/35790091", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cnr2.1672" } }, { "@type": "ScholarlyArticle", "name": "Association of Ki-67 Change Pattern After Core Needle Biopsy and Prognosis in HR+/HER2- Early Breast Cancer Patients.", "datePublished": "2022-06-28", "url": "https://questionsmedicales.fr/article/35836600", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fsurg.2022.905575" } }, { "@type": "ScholarlyArticle", "name": "Impact of Early Jejunostomy Tube Feeding on Clinical Outcome and Parameters of Body Composition in Esophageal Cancer Patients Receiving Multimodal Therapy.", "datePublished": "2022-05-26", "url": "https://questionsmedicales.fr/article/35616747", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1245/s10434-022-11754-3" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Signes et symptômes", "item": "https://questionsmedicales.fr/mesh/D012816" }, { "@type": "ListItem", "position": 4, "name": "Manifestations neurologiques", "item": "https://questionsmedicales.fr/mesh/D009461" }, { "@type": "ListItem", "position": 5, "name": "Troubles sensitifs", "item": "https://questionsmedicales.fr/mesh/D012678" }, { "@type": "ListItem", "position": 6, "name": "Troubles de l'audition", "item": "https://questionsmedicales.fr/mesh/D006311" }, { "@type": "ListItem", "position": 7, "name": "Perte d'audition", "item": "https://questionsmedicales.fr/mesh/D034381" }, { "@type": "ListItem", "position": 8, "name": "Surdité mixte de transmission et neurosensorielle", "item": "https://questionsmedicales.fr/mesh/D046089" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Surdité mixte de transmission et neurosensorielle - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Surdité mixte de transmission et neurosensorielle", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Surdité mixte de transmission et neurosensorielle", "description": "Comment diagnostiquer la surdité mixte ?\nQuels examens sont nécessaires ?\nQuels signes indiquent une surdité mixte ?\nPeut-on détecter la surdité mixte chez les enfants ?\nQuel spécialiste consulte-t-on pour ce diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D046089?mesh_terms=Early+Detection+of+Cancer&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Surdité mixte de transmission et neurosensorielle", "description": "Quels sont les symptômes de la surdité mixte ?\nLa surdité mixte cause-t-elle des douleurs ?\nY a-t-il des signes d'alerte ?\nLes enfants montrent-ils des symptômes différents ?\nLes symptômes varient-ils selon l'âge ?", "url": "https://questionsmedicales.fr/mesh/D046089?mesh_terms=Early+Detection+of+Cancer&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Surdité mixte de transmission et neurosensorielle", "description": "Comment prévenir la surdité mixte ?\nLes protections auditives sont-elles utiles ?\nFaut-il éviter certains médicaments ?\nLes examens réguliers sont-ils nécessaires ?\nL'éducation sur la santé auditive est-elle importante ?", "url": "https://questionsmedicales.fr/mesh/D046089?mesh_terms=Early+Detection+of+Cancer&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Surdité mixte de transmission et neurosensorielle", "description": "Quels traitements sont disponibles ?\nLes médicaments peuvent-ils aider ?\nQuand envisager une chirurgie ?\nLes appareils auditifs sont-ils efficaces ?\nY a-t-il des thérapies alternatives ?", "url": "https://questionsmedicales.fr/mesh/D046089?mesh_terms=Early+Detection+of+Cancer&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Surdité mixte de transmission et neurosensorielle", "description": "Quelles complications peuvent survenir ?\nLa surdité mixte peut-elle affecter la qualité de vie ?\nY a-t-il des risques de dépression ?\nLes complications sont-elles réversibles ?\nComment gérer les complications ?", "url": "https://questionsmedicales.fr/mesh/D046089?mesh_terms=Early+Detection+of+Cancer&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Surdité mixte de transmission et neurosensorielle", "description": "Quels sont les facteurs de risque ?\nL'âge est-il un facteur de risque ?\nLes maladies chroniques influencent-elles ?\nLes traumatismes crâniens sont-ils un risque ?\nLes infections de l'oreille sont-elles un facteur ?", "url": "https://questionsmedicales.fr/mesh/D046089?mesh_terms=Early+Detection+of+Cancer&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer la surdité mixte ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un audiogramme et des tests d'imagerie sont utilisés pour évaluer la perte auditive." } }, { "@type": "Question", "name": "Quels examens sont nécessaires ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des examens cliniques, audiométriques et parfois une IRM sont nécessaires." } }, { "@type": "Question", "name": "Quels signes indiquent une surdité mixte ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des difficultés à entendre dans des environnements bruyants et des sons étouffés." } }, { "@type": "Question", "name": "Peut-on détecter la surdité mixte chez les enfants ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests auditifs peuvent être réalisés dès la naissance pour détecter cette condition." } }, { "@type": "Question", "name": "Quel spécialiste consulte-t-on pour ce diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Un oto-rhino-laryngologiste (ORL) est le spécialiste à consulter pour ce diagnostic." } }, { "@type": "Question", "name": "Quels sont les symptômes de la surdité mixte ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent une perte auditive variable, des acouphènes et des difficultés de compréhension." } }, { "@type": "Question", "name": "La surdité mixte cause-t-elle des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut causer des douleurs si des infections de l'oreille sont présentes." } }, { "@type": "Question", "name": "Y a-t-il des signes d'alerte ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des difficultés soudaines à entendre ou des bruits étranges peuvent être des signes d'alerte." } }, { "@type": "Question", "name": "Les enfants montrent-ils des symptômes différents ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent avoir des retards de langage ou des difficultés scolaires." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées en raison de la dégénérescence." } }, { "@type": "Question", "name": "Comment prévenir la surdité mixte ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les bruits forts, traiter rapidement les infections de l'oreille et faire des bilans auditifs réguliers." } }, { "@type": "Question", "name": "Les protections auditives sont-elles utiles ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles protègent contre les dommages auditifs dans des environnements bruyants." } }, { "@type": "Question", "name": "Faut-il éviter certains médicaments ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments ototoxiques doivent être évités pour prévenir des dommages auditifs." } }, { "@type": "Question", "name": "Les examens réguliers sont-ils nécessaires ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens auditifs réguliers aident à détecter précocement des problèmes auditifs." } }, { "@type": "Question", "name": "L'éducation sur la santé auditive est-elle importante ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sensibiliser à la santé auditive aide à prévenir des pertes auditives futures." } }, { "@type": "Question", "name": "Quels traitements sont disponibles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des appareils auditifs, des implants cochléaires et des interventions chirurgicales." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments peuvent être prescrits pour traiter des infections ou des inflammations associées." } }, { "@type": "Question", "name": "Quand envisager une chirurgie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est envisagée si des anomalies structurelles causent la perte auditive." } }, { "@type": "Question", "name": "Les appareils auditifs sont-ils efficaces ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils améliorent souvent la capacité d'écoute, surtout dans des environnements calmes." } }, { "@type": "Question", "name": "Y a-t-il des thérapies alternatives ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Certaines thérapies alternatives peuvent aider, mais leur efficacité n'est pas toujours prouvée." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles de l'équilibre, des infections récurrentes et des difficultés sociales." } }, { "@type": "Question", "name": "La surdité mixte peut-elle affecter la qualité de vie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des problèmes de communication et d'interaction sociale." } }, { "@type": "Question", "name": "Y a-t-il des risques de dépression ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la perte auditive peut augmenter le risque de dépression et d'anxiété." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être traitées, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une prise en charge multidisciplinaire est souvent nécessaire pour gérer les complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des infections fréquentes et l'exposition au bruit." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement augmente le risque de surdité mixte en raison de la dégénérescence auditive." } }, { "@type": "Question", "name": "Les maladies chroniques influencent-elles ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme le diabète peuvent augmenter le risque de perte auditive." } }, { "@type": "Question", "name": "Les traumatismes crâniens sont-ils un risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traumatismes crâniens peuvent endommager les structures auditives et provoquer une surdité." } }, { "@type": "Question", "name": "Les infections de l'oreille sont-elles un facteur ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections récurrentes peuvent endommager l'oreille moyenne et interne, augmentant le risque." } } ] } ] }

Sources (10000 au total)

Imaging-Based Deep Graph Neural Networks for Survival Analysis in Early Stage Lung Cancer Using CT: A Multicenter Study.

Lung cancer is the leading cause of cancer-related mortality, and accurate prediction of patient survival can aid treatment planning and potentially improve outcomes. In this study, we proposed an aut... In this retrospective study, we segmented 10 parts of the lung CT images and built individual lung graphs as inputs to train a GCN model to predict 5-year overall survival. A Cox proportional-hazard m... A total of 1,705 patients (main cohort) and 125 patients (external validation cohort) with lung cancer (stages I and II) were included. The GCN model was significantly predictive of 5-year overall sur... The proposed GCN model outperformed all ML, Tumor-CNN, and TNM staging models. This study demonstrated the value of utilizing medical imaging graph structure data, resulting in a robust and effective ...

Toxicity and outcomes after external beam irradiation for prostate cancer in patients with prior holmium laser enucleation of the prostate: Early experience.

Holmium laser enucleation of the prostate (HoLEP) is commonly performed in patients with significant bladder outlet obstruction. However, there are few reports on the toxicity of external beam irradia... Eighteen patients who had HoLEP and subsequently received RT for prostate cancer were included. Data collected included patient and disease characteristics, urinary function, and radiation dose. Acute... Median follow-up was 18 months (range: 4-46 months). Median prostate volume was 107 ml before HoLEP and 24 ml after HoLEP. Median International Prostate Symptom Score (IPSS) was 17 (range: 5-32) befor... Patients who received RT as definitive treatment for prostate cancer after prior HoLEP had low risk of serious acute and late side effects. HoLEP can be safely performed and should be considered in pa...

Association of Ki-67 Change Pattern After Core Needle Biopsy and Prognosis in HR+/HER2- Early Breast Cancer Patients.

To investigate the association of Ki-67 change pattern after core needle biopsy (CNB) and prognosis in HR+/HER2- early breast cancer patients.... Eligible patients were categorized into three groups: Low group, Elevation group, and High group. Chi-square test and logistic regression analysis were used to compare the clinic-pathological characte... A total of 2,858 patients were included: 1,179 (41.3%), 482 (16.9%), and 1,197 (41.8%) patients were classified into the low, elevation, and high groups, respectively. Age, tumor size, histological gr... Ki-67 change after CNB was associated with prognosis in HR+/HER2- early breast cancer. Patients with Ki-67 high or elevation after CNB had an inferior disease outcome, indicating the necessity of re-e...

Impact of Early Jejunostomy Tube Feeding on Clinical Outcome and Parameters of Body Composition in Esophageal Cancer Patients Receiving Multimodal Therapy.

Malnutrition commonly affects patients with esophageal cancer and has the potential to negatively influence treatment outcomes. The aim of this study was to investigate the impact of early (preoperati... Patients were selected to undergo early JTF during neoadjuvant chemoradiotherapy (nCRT) in accordance with European Society for Clinical Nutrition and Metabolism (ESPEN) and Enhanced Recovery after Su... In total, 81 patients received early JTF and 91 patients received routine JTF. Patients who received early JTF had lower body mass index (BMI; 26.1 ± 4.6 vs. 28.4 ± 4.9; p = 0.002), greater weight los... In patients determined to be at 'high risk' of malnutrition, early JTF may prevent excess morbidity after esophagectomy with an associated relative preservation of parameters of body composition....

Clinical significance of serum estradiol monitoring in women receiving adjuvant aromatase inhibitor for hormone receptor-positive early breast cancer.

The limited understanding of long-term estradiol (E2) suppression poses challenges to the effectiveness of adjuvant therapy with aromatase inhibitors (AI), necessitating comprehensive serum E2 monitor... In this prospective cohort study, we recruited women who had received adjuvant AI treatment, including those who underwent ovarian function suppression (OFS). Serum E2 levels were measured using high-... A total of 706 patients were enrolled, including 482 women with OFS in combination with AI. Among them, 116 women (16.4 %) exhibited E2 levels exceeding 2.72 pg/mL. The majority of serum E2 elevations... Despite receiving adjuvant AI treatment for nearly two years, a certain proportion of patients failed to achieve the adequate threshold of E2 suppression. Our findings emphasize the significance of mo...

Comparison of clinical outcomes in women with surgically treated early primary cervical cancer: Lymphadenectomy versus sentinel lymph node biopsy.

The primary objective of this study was to elucidate the impact of sentinel lymph node (SLN) mapping and biopsy techniques on the clinical outcomes of women with early primary cervical cancer.... All consecutive women with clinically determined stage I-IIA cervical cancer who underwent lymph node assessment with either SLN mapping or conventional pelvic/para-aortic lymphadenectomy were reviewe... Women in the SLN group (n=33) had fewer total dissected pelvic nodes (8.3±5.9 versus 17.4±7.7, p<0.001), less intraoperative blood loss (513±332mL versus 1228±1170mL, p<0.001), a shorter length of hos... SLN biopsy does not seem to be associated with an inferior survival outcome compared with conventional lymphadenectomy in women with early primary cervical cancer. In addition, it is associated with l...

Comparison analysis of the burden and attributable risk factors of early-onset and late-onset colorectal cancer in China from 1990 to 2019.

The project intended to analyze the impact of burden and related risk factors of late-onset colorectal cancer (LOCRC) and early-onset colorectal cancer (EOCRC) in China, thus offering essential refere... Global Burden of Disease Study was employed to describe burden changes of EOCRC and LOCRC in China during 1990-2019, containing the numbers of incidence, deaths, prevalence, and disability-adjusted li... The numbers and corresponding crude rates of incidence, deaths, prevalence, and DALYs of EOCRC and LOCRC in China during 1990-2019 demonstrated an upward trend across all age categories, with males be... The burden of colorectal cancer in China is concerning. Patients grouped by diagnostic age exhibit different characteristics, indicating the need for high-quality research in the future to achieve per...

Clinical characteristics and radiation therapy modality of younger patients with early-stage endometrial cancer, a multicenter study in China's real world.

Endometrial cancer is a prevalent gynecologic malignancy found in postmenopausal women. However, in the last two decades, the incidence of early-stage has doubled in women under 40 years old. This stu... This retrospective study analyzed patients with early-stage endometrial cancer at 13 medical institutions in China from 1999 to 2015. The patients were divided into two groups: young (≤ 45 years old) ... The study involved 1,280 patients, 150 of whom were 45 years old or younger. The young group exhibited a significantly higher proportion of stage II, low-risk, lower uterine segment infiltration (LUSI... In the present study, young patients had better characteristics than the non-young group, while they exhibited higher levels of aggressiveness in certain aspects. The LRFS and OS outcomes were better ...